(Q44589868)

4 December 2017

title

Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial (English)

1 reference

4 December 2017

0 references

1 reference

1 reference

chronic schizophrenia

1 reference

1

1 reference

4 December 2017

5

Bagher Larijani

1 reference

4 December 2017

Ali Akbar Nejatisafa

2

1 reference

4 December 2017

Homayoun Amini

3

1 reference

4 December 2017

Mohammad Reza Mohammadi

4

1 reference

4 December 2017

Ladan Kashani

6

1 reference

4 December 2017

Firoozeh Raisi

7

1 reference

4 December 2017

Abbas Kamalipour

8

1 reference

4 December 2017

publication date

1 September 2003

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

4 December 2017

published in

1 reference

4 December 2017

volume

27

1 reference

4 December 2017

issue

6

1 reference

4 December 2017

page(s)

1007-1012

1 reference

Neurotransmitter interactions in schizophrenia--therapeutic implications

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Modulation of brain dopamine transmission by sex steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Neuroprotection by estradiol.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Gender differences in the course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

How does gender influence age at first hospitalization for schizophrenia? A transnational case register study

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

The positive and negative syndrome scale (PANSS) for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Neuroprotective effects of estradiol-17beta: implications for psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

A clinical trial of the effects of estrogen in acutely psychotic women

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Estrogen - a potential treatment for schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

A clinical trial of adjunctive oestrogen treatment in women with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Neurotrophic and neuroprotective actions of estrogens and their therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Oestrogen effects in schizophrenia and their potential therapeutic implications--review

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Oestrogens and schizophrenia - Introduction

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Interaction of sex, age, and neuroleptic dose

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Schizophrenia: reproductive hormones and the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

Extrapyramidal symptoms and oestrogen

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2803%2900161-1

7 January 2021

10.1016/S0278-5846(03)00161-1

Identifiers

DOI

1 reference

4 December 2017

1 reference